|
Source Letter MHRA 16/2/06 - A letter from Professor G Duff, Chairman, Commission on Human Medicines dated 16/2/06, issues new advice to prescribers regarding the potential risk of seizure with Strattera and reports QT interval prolongation.
For more information go to the MHRA website:
http://www.mhra.gov.uk/home/idcpig?ldcService=SS_Get_PAGE&useSecond ary=true&ssDocName=CON2023223&ssTargetNodeld=389
Prepared by Susan Wileman Medicines Information Technician
Date of Preparation: 16th February 2006
|
